X4 Pharmaceuticals Appoints Kelly Gold as Independent Director
X4 Pharmaceuticals (XFOR) announced the appointment of Kelly Gold to the company's board of directors effective July 1, adding strong strategic and financial expertise. Gold will serve as an independent director and member of the audit committee. Gold is currently the CFO at CAMP4 Therapeutics (CAMP).
